MXPA03010363A - Metodo para tratar hipertension ocular y glaucoma. - Google Patents

Metodo para tratar hipertension ocular y glaucoma.

Info

Publication number
MXPA03010363A
MXPA03010363A MXPA03010363A MXPA03010363A MXPA03010363A MX PA03010363 A MXPA03010363 A MX PA03010363A MX PA03010363 A MXPA03010363 A MX PA03010363A MX PA03010363 A MXPA03010363 A MX PA03010363A MX PA03010363 A MXPA03010363 A MX PA03010363A
Authority
MX
Mexico
Prior art keywords
glaucoma
ocular hypertension
treating ocular
compound
eye
Prior art date
Application number
MXPA03010363A
Other languages
English (en)
Spanish (es)
Inventor
Ueno Ryuji
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of MXPA03010363A publication Critical patent/MXPA03010363A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03010363A 2001-05-14 2002-05-13 Metodo para tratar hipertension ocular y glaucoma. MXPA03010363A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29035501P 2001-05-14 2001-05-14
PCT/JP2002/004600 WO2002092098A1 (en) 2001-05-14 2002-05-13 Method for treating ocular hypertension and glaucoma

Publications (1)

Publication Number Publication Date
MXPA03010363A true MXPA03010363A (es) 2004-03-16

Family

ID=23115609

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010363A MXPA03010363A (es) 2001-05-14 2002-05-13 Metodo para tratar hipertension ocular y glaucoma.

Country Status (10)

Country Link
US (1) US20050014837A1 (https=)
EP (1) EP1390035A1 (https=)
JP (1) JP2004529177A (https=)
KR (1) KR20040008174A (https=)
CN (1) CN1525861A (https=)
BR (1) BR0209601A (https=)
CA (1) CA2444627A1 (https=)
MX (1) MXPA03010363A (https=)
NO (1) NO20035043D0 (https=)
WO (1) WO2002092098A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082257A2 (en) * 2002-03-28 2003-10-09 Sucampo Ag Method for treating ocular hypertension and glaucoma
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
ES2431640T3 (es) * 2003-08-21 2013-11-27 Sucampo Ag Composición oftálmica que comprende éster isopropílico de unoprostona y un agente de viscosidad
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US9061034B2 (en) 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
KR101820184B1 (ko) * 2010-07-29 2018-01-18 알러간, 인코포레이티드 방부제가 없는 비마토프로스트 및 티몰롤 용액

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
EP0458588B1 (en) * 1990-05-22 1994-11-30 R-Tech Ueno Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
PT561073E (pt) * 1992-03-19 2002-04-29 R Tech Ueno Ltd Tratamento da hipertensao ocular com beta-bloqueadores e derivados de acido prostanoico
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
JP5011548B2 (ja) * 1998-12-25 2012-08-29 株式会社アールテック・ウエノ 高眼圧症あるいは緑内障の処置用医薬組成物
US6458836B1 (en) * 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma

Also Published As

Publication number Publication date
CN1525861A (zh) 2004-09-01
WO2002092098A1 (en) 2002-11-21
EP1390035A1 (en) 2004-02-25
JP2004529177A (ja) 2004-09-24
BR0209601A (pt) 2004-03-23
CA2444627A1 (en) 2002-11-21
NO20035043D0 (no) 2003-11-13
KR20040008174A (ko) 2004-01-28
US20050014837A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
CA1314220C (en) Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
WO2002080811A3 (en) Glaucoma stent and methods thereof for glaucoma treatment
CA2440764A1 (en) Combination of brimonidine and timolol for topical ophthalmic use
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
WO2004026347A3 (en) Apparatus and method for surgical bypass of aqueous humor
WO2005105197A3 (en) Indwelling shunt device and methods for treating glaucoma
PT868186E (pt) Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
PL369246A1 (en) Ophthalmic drug delivery device
WO2002096318A3 (en) Method for treating glaucoma v
WO2003092584A3 (en) Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
WO2001041685A3 (en) Treatment of ocular disease
WO2002089699A3 (en) Medical device and methods of use for glaucoma treatment
WO2009137085A8 (en) Sustained release delivery of active agents to treat glaucoma and ocular hypertension
WO2002062385A3 (en) Method to prevent vision loss
CA2502437A1 (en) Method and composition containing latanoprost for treating ocular hypertension and glaucoma
EP1545655A4 (en) IMPLANTABLE OXULAR PUMP FOR REDUCING EYE REMINDER
WO2006066103A3 (en) Ophthalmic implant for treatment of glaucoma
PL362803A1 (en) Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
WO2002009702A8 (en) Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
WO2003072066A3 (en) Compositions and methods for the treatment of glaucoma and ocular hypertension
ATE359794T1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
MXPA03010363A (es) Metodo para tratar hipertension ocular y glaucoma.
CA2505086A1 (en) Ophthalmic compositions for treating ocular hypertension